Clinical Trials
- Heart/Cardiovascular
TARGET BP I Clinical Trial (TARGET BP I)
- Ages18 years - 80 years
- GenderBoth
- Heart/Cardiovascular
Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (ACACIA)
- Heart/Cardiovascular
SCOPE-CLI: Shifting Care and Outcomes for Patients with Endangered limbs Critical Limb Ischemia
- Ages19 years and older
- GenderBoth
- Heart/Cardiovascular
Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
SELUTION4SFA: A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Efficacy of the SELUTION SLR 018 Drug Eluting Balloon in the Treatment of Subjects with Femoro popliteal Artery Lesions
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Double blind randomized autologous stem cell trial treatment for peripheral arterial disease (PAD) with critical limb threatening ischemia
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy (MAPLE)
- Ages18 years - 85 years
- GenderBoth
- Heart/Cardiovascular
Women FiRST: Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
- Heart/Cardiovascular
The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
INSPIRE Pipelineā¢ Shield Post Approval Study
- Ages22 years and older
- GenderBoth